Diagnostics, Prognostic and Therapeutic Exploitation of Telomeres and Telomerase in Leukemias

E-ISSN： 1873-4316|7|3|171-183

ISSN： 1389-2010

Source： Current Pharmaceutical Biotechnology, Vol.7, Iss.3, 2006-01, pp. : 171-183

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Telomeres and telomerase: targets for cancer chemotherapy?

By Perry P.J. Kelland L.R.

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 12, 1998-12 ,pp. : 1567-1586

Informa Healthcare

Access to resources Recommend Favorite

Telomeres and Telomerase: Pharmacological Targets for New Anticancer Strategies?

Current Cancer Drug Targets, Vol. 6, Iss. 2, 2006-01 ,pp. : 147-180

Bentham Science Publishers

Access to resources Recommend Favorite

Telomerase Modulation in Therapeutic Approach

Current Pharmaceutical Design, Vol. 20, Iss. 41, 2014-12 ,pp. : 6438-6451

Bentham Science Publishers

Access to resources Recommend Favorite

Telomeres, telomerase, and reversed transcription and haemopoietic cells with short-term repopulation

Reproductive BioMedicine Online, Vol. 13, Iss. 6, 2006-12 ,pp. : 839-839

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Oligonucleotides and G-quadruplex Stabilizers: Targeting Telomeres and Telomerase in Cancer Therapy

Current Pharmaceutical Design, Vol. 20, Iss. 41, 2014-12 ,pp. : 6422-6437

Bentham Science Publishers

Access to resources Recommend Favorite